A Randomized, Multicentric, Double-Blind, Active Controlled, Parallel Group, Phase III, Non-Inferiority Clinical Trial To Evaluate The Efficacy, Safety And Tolerability Of Oral Semaglutide Tablets Of Dr. Reddy’s Laboratories Ltd. Compared With Rybelsus® (Semaglutide) Tablets In Adult Patients With Inadequately Controlled Type 2 Diabetes Mellitus.
Journal of Clinical Endocrinology and Metabolism · 2026
DOI: 10.52338/jocem.2026.6017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Endocrinology and Metabolism, 2026. Verfasst von Dilip Shah und 24 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
To Evaluate The Efficacy, Safety And Tolerability Of Oral Semag-Lutide Tablets Of Dr
Zitieren
APA
Shah, D., Ramamohan, M. V., Mehta, K., Shejole, V., Murthy, S. S., Gupta, S., Samaria, A., Sosale, B., Dube, Y. P., Basu, U., Mullick, S., Agarwal, D., Rao, V., Gopalakrishnan, U. A., Sahlot, R., Agarwal, P. K., Das, S., Baidya, A., Pattnaik, I., …, & Somagoni, J. (2026). A Randomized, Multicentric, Double-Blind, Active Controlled, Parallel Group, Phase III, Non-Inferiority Clinical Trial To Evaluate The Efficacy, Safety And Tolerability Of Oral Semaglutide Tablets Of Dr. Reddy’s Laboratories Ltd. Compared With Rybelsus® (Semaglutide) Tablets In Adult Patients With Inadequately Controlled Type 2 Diabetes Mellitus. Journal of Clinical Endocrinology and Metabolism. https://doi.org/10.52338/jocem.2026.6017
Vancouver
Shah D, Ramamohan MV, Mehta K, Shejole V, Murthy SS, Gupta S, et al. A Randomized, Multicentric, Double-Blind, Active Controlled, Parallel Group, Phase III, Non-Inferiority Clinical Trial To Evaluate The Efficacy, Safety And Tolerability Of Oral Semaglutide Tablets Of Dr. Reddy’s Laboratories Ltd. Compared With Rybelsus® (Semaglutide) Tablets In Adult Patients With Inadequately Controlled Type 2 Diabetes Mellitus. Journal of Clinical Endocrinology and Metabolism. 2026. doi:10.52338/jocem.2026.6017
BibTeX
@article{Shah2026,
author = {Shah, Dilip and Ramamohan, Mamidala Venkata and Mehta, Ketan and Shejole, Vivek and Murthy, S. Satyanarayana and Gupta, Sachin and Samaria, Anil and Sosale, Bhavana and Dube, Yatindra Prasad and Basu, Utsa and Mullick, Sagorika and Agarwal, Dinesh and Rao, Venkateshwar and Gopalakrishnan, Unnikrishnan Ambika and Sahlot, Rahul and Agarwal, Prabhat Kumar and Das, Sambit and Baidya, Arjun and Pattnaik, Indira and Kale, Shailaja and Agarwal, Piyush and Saini, Anuj Kumar and Wani, Swarup Rajendra and Ch, Eeshitha and Somagoni, Jaganmohan},
title = {A Randomized, Multicentric, Double-Blind, Active Controlled, Parallel Group, Phase III, Non-Inferiority Clinical Trial To Evaluate The Efficacy, Safety And Tolerability Of Oral Semaglutide Tablets Of Dr. Reddy’s Laboratories Ltd. Compared With Rybelsus® (Semaglutide) Tablets In Adult Patients With Inadequately Controlled Type 2 Diabetes Mellitus},
journal = {Journal of Clinical Endocrinology and Metabolism},
year = {2026},
doi = {10.52338/jocem.2026.6017}
}
EUVIMED